Adlai Nortye (ANL) Invested Capital (2022 - 2025)
Adlai Nortye's (ANL) quarterly Invested Capital came in at $26.7 million in Q4 2025, down 2.26% year-on-year from $27.4 million in Q4 2024, and down 2.26% on a QoQ basis from $27.4 million in Q4 2024.
Adlai Nortye (ANL) Invested Capital (2022 - 2025) Analysis & Trends
Adlai Nortye (ANL) has 4 years of Invested Capital data on file, last reported at $26.7 million in Q4 2025.
- On a quarterly basis, Invested Capital fell 2.26% year-over-year to $26.7 million in Q4 2025; TTM through Dec 2025 was $54.1 million, a 84.8% decrease from a year earlier, with the FY2025 full-year figure at $26.7 million, down 2.26% from the prior year.
- Invested Capital for Q4 2025 stood at $26.7 million, down from $27.4 million in the prior quarter.
- Over the last five years, Invested Capital for ANL reached as high as $296.9 million in Q4 2022 and fell as low as $26.7 million in Q4 2025.
- Historically, Invested Capital has averaged $95.7 million across 4 years, with a median of $29.5 million in 2023.
- Across the five-year window, Invested Capital slumped 89.34% in 2023 and dropped 2.26% in 2025, its largest moves.
- Year by year, Invested Capital stood at $296.9 million in 2022, then slumped by 89.34% to $31.7 million in 2023, then declined by 13.58% to $27.4 million in 2024, then dropped by 2.26% to $26.7 million in 2025.
- Per Business Quant data, the three most recent Invested Capital figures were $26.7 million in Q4 2025, $27.4 million in Q4 2024, and $31.7 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adlai Nortye | 1.27 Bn | 1.26 Bn | - | 26.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.74 Mn |
| Dec 31, 2024 | 27.36 Mn |
| Dec 31, 2023 | 31.66 Mn |
| Dec 31, 2022 | 296.92 Mn |